Hepbest 25 mg Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Hepbest 25 mg Tablet contains tenofovir alafenamide, a nucleotide reverse transcriptase inhibitor (antiviral). Its labelling describes it for the treatment of chronic hepatitis B virus (HBV) infection and HIV-1 infection, and it is described as stopping the multiplication of the virus in the body’s cells. The prescriber decides whether it is taken with or without food.
Product Information
The following description reflects information associated with tenofovir alafenamide and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of chronic hepatitis B virus (HBV) infection
- Described for the treatment of HIV-1 infection
- Described as stopping the multiplication of the virus in the body’s cells
Described Dosage & Administration
- Taken by mouth at the dose set by the doctor, who decides whether it is taken with or without food
- Doses should not be skipped, and the course should be completed even if the patient feels better
- Treatment should not be stopped without asking the doctor
Described Side Effects
Commonly described side effects include:
- Headache
- Diarrhoea
- Nausea
- Indigestion
Rarely, skin reactions or liver problems are described, which the doctor checks for at the start of treatment. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- The doctor should be told about any skin problems or liver or kidney problems
- Regular blood tests for blood count and liver function are described as recommended during treatment
- Alcohol should be avoided, as it is described as possibly leading to liver damage
- Pregnant women and breastfeeding mothers should consult their doctor before taking the medicine; a person who is HIV positive is advised to take precautions during sex and not share personal items
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains tenofovir alafenamide and is used to treat chronic hepatitis B virus infection and HIV-1 infection, described as stopping the virus from multiplying in the body’s cells. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as taken by mouth at the dose set by the doctor, who decides whether it is taken with or without food. Doses should not be skipped and treatment should not be stopped without asking the doctor.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.